Bethesda, MD, United States of America

Giacomo Gorini

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giacomo Gorini: Innovator in HIV Research

Introduction

Giacomo Gorini is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of HIV research, particularly through his innovative work on recombinant proteins. His research aims to enhance the understanding and treatment of HIV-1 infections.

Latest Patents

Gorini holds a patent for the "Recombinant gp120 protein with V1-loop deletion." This patent discloses embodiments of recombinant HIV-1 gp120 proteins that contain a V1 deletion. Additionally, it includes gp140, gp145, and gp160 proteins with the same deletion, as well as HIV-1 Env ectodomain trimers containing these modified proteins. The patent also provides nucleic acid molecules encoding these proteins. The disclosed recombinant HIV-1 proteins and nucleic acid molecules can potentially be used to generate an immune response to HIV-1 in subjects, aiding in the treatment or prevention of HIV-1 infections.

Career Highlights

Throughout his career, Giacomo Gorini has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and New York University. His work has been instrumental in advancing the scientific community's understanding of HIV.

Collaborations

Gorini has collaborated with esteemed colleagues such as Genoveffa Franchini and Timothy J Cardozo. These collaborations have further enriched his research and contributed to the development of innovative solutions in the fight against HIV.

Conclusion

Giacomo Gorini's contributions to HIV research through his patented innovations highlight his role as a key figure in the scientific community. His work continues to pave the way for advancements in the treatment and prevention of HIV-1 infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…